EichorEICHOR
Location: Prague Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Prague

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Fakultni poliklinika · Pfizer · NCT05020236A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Clintrial s.r.o. · AbbVie · NCT06602479A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Fakultni nemocnice Kralovske Vinohrady · Eli Lilly and Company · NCT07218380Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Medicon a.s. · Philip Morris Products S.A. · NCT07108166Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NA · University Hospital, Kralovske Vinohrady · University Hospital, Geneva · NCT06207383This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Urocentrum Praha s.r.o. · Pfizer · NCT07028853Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Phase N/A · Institute of Hematology and Blood Transfusion, Coagulation L · Insel Gruppe AG, University Hospital Bern · NCT01257269Invasive Candidiasis in Critical Care
Phase N/A · University Hospital Motol · University Hospital Ostrava · NCT06456151Feasibility Study of the FARAFLEX Mapping and PFA System
NA · Nemocnice Na Homolce Hospital · Boston Scientific Corporation · NCT06510556A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · Fakultni Thomayerova nemocnice · eleva GmbH · NCT07483827Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Hospital Motol V Uvalu 841 · Princess Maxima Center for Pediatric Oncology · NCT05327894A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Vseobecna fakultni nemocnice v Praze-I. Interní klinika - kl · Merck Sharp & Dohme LLC · NCT06136559Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes
NA · University Hospital Motol · University Hospital, Motol · NCT07149142Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0041 · Bristol-Myers Squibb · NCT07106762Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Vseobecna fakultni nemocnice v Praze-Onkologická klinika VFN · Merck Sharp & Dohme LLC · NCT06393374A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Phase 2 · ISCARE a.s. · Boehringer Ingelheim · NCT06636656Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
Phase N/A · Department of Neurology, Motol University Hospital, Second F · University Hospital Tuebingen · NCT06472557This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Fakultni Thomayerova nemocnice · Pfizer · NCT06758401A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site CZ42001 · Astellas Pharma Global Development, Inc. · NCT05970172A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Vseobecna fakultni nemocnice v Praze · Pfizer · NCT07073820STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pa
NA · Ustredni vojenska nemocnice · Lipidica, a.s. · NCT06549725Lifestyle Modification in the Treatment of NAFLD.
NA · General University Hospital · General University Hospital, Prague · NCT05816915Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Fakultni nemocnice v Motole · PedAL BCU, LLC · NCT05183035Randomization of Single vs Multiple Arterial Grafts
NA · General University Hospital, Prague · Weill Medical College of Cornell University · NCT03217006Aftificial Inteligence in Assisted Reproductive Techniques to Assess Oocyte Quality and Embryo Ploidy
Phase N/A · General University Hospital in Prague · Charles University, Czech Republic · NCT06539104Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic
Phase N/A · University Hospital Motol · University Hospital, Motol · NCT07103317Early Detection of OAB and Elimination of Negative Impact on Quality of Life
NA · General University Hospital · Institute of Health Information and Statistics of the Czech · NCT07371000Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Kardiologie a Angiologie Praha sro - Komplexni Centrum Vyzku · Amgen · NCT07037433
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.